Sulpiride: A study of the effects on dopamine receptors in rat neostriatum and limbic forebrain

M. Trabucchi; R. Longoni; P. Fresia; P. F. Spano

doi:10.1016/0024-3205(75)90176-9

Sulpiride: A study of the effects on dopamine receptors in rat neostriatum and limbic forebrain

M. Trabucchi, R. Longoni, P. Fresia, P. F. Spano

Istituto di Neuroriabilitazione Motoria San Camillo

Research output: Contribution to journal › Article › peer-review

Abstract

Sulpiride is a new neuroleptic which does not produce extrapyramidal side effects in humans nor catalepsy in experimental animals. Sulpiride in rat striatum and nucleus accumbens homogenates fails to block adenylate cyclase activation induced by both dopamine and apomorphine. Moreover the in vivo cyclic adenosine monophosphate accumulation induced by apomorphine in the striatum of rats is not blocked by sulpiride as haloperidol and other classic neuroleptic do. Sulpiride appears to be unique in respect to other neuroleptic since according to the experiments reported in this paper it does not block dopamine receptors either in vitro or in vivo.

Original language	English
Pages (from-to)	1551-1556
Number of pages	6
Journal	Life Sciences
Volume	17
Issue number	10
DOIs	https://doi.org/10.1016/0024-3205(75)90176-9
Publication status	Published - Nov 15 1975

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1016/0024-3205(75)90176-9

Fingerprint Dive into the research topics of 'Sulpiride: A study of the effects on dopamine receptors in rat neostriatum and limbic forebrain'. Together they form a unique fingerprint.

Cite this

@article{2d4ef1d1488f4fe3a348b622f383351e,

title = "Sulpiride: A study of the effects on dopamine receptors in rat neostriatum and limbic forebrain",

abstract = "Sulpiride is a new neuroleptic which does not produce extrapyramidal side effects in humans nor catalepsy in experimental animals. Sulpiride in rat striatum and nucleus accumbens homogenates fails to block adenylate cyclase activation induced by both dopamine and apomorphine. Moreover the in vivo cyclic adenosine monophosphate accumulation induced by apomorphine in the striatum of rats is not blocked by sulpiride as haloperidol and other classic neuroleptic do. Sulpiride appears to be unique in respect to other neuroleptic since according to the experiments reported in this paper it does not block dopamine receptors either in vitro or in vivo.",

author = "M. Trabucchi and R. Longoni and P. Fresia and Spano, {P. F.}",

year = "1975",

month = nov,

day = "15",

doi = "10.1016/0024-3205(75)90176-9",

language = "English",

volume = "17",

pages = "1551--1556",

journal = "Life Sciences",

issn = "0024-3205",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - Sulpiride

T2 - A study of the effects on dopamine receptors in rat neostriatum and limbic forebrain

AU - Trabucchi, M.

AU - Longoni, R.

AU - Fresia, P.

AU - Spano, P. F.

PY - 1975/11/15

Y1 - 1975/11/15

N2 - Sulpiride is a new neuroleptic which does not produce extrapyramidal side effects in humans nor catalepsy in experimental animals. Sulpiride in rat striatum and nucleus accumbens homogenates fails to block adenylate cyclase activation induced by both dopamine and apomorphine. Moreover the in vivo cyclic adenosine monophosphate accumulation induced by apomorphine in the striatum of rats is not blocked by sulpiride as haloperidol and other classic neuroleptic do. Sulpiride appears to be unique in respect to other neuroleptic since according to the experiments reported in this paper it does not block dopamine receptors either in vitro or in vivo.

AB - Sulpiride is a new neuroleptic which does not produce extrapyramidal side effects in humans nor catalepsy in experimental animals. Sulpiride in rat striatum and nucleus accumbens homogenates fails to block adenylate cyclase activation induced by both dopamine and apomorphine. Moreover the in vivo cyclic adenosine monophosphate accumulation induced by apomorphine in the striatum of rats is not blocked by sulpiride as haloperidol and other classic neuroleptic do. Sulpiride appears to be unique in respect to other neuroleptic since according to the experiments reported in this paper it does not block dopamine receptors either in vitro or in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0016676004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016676004&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(75)90176-9

DO - 10.1016/0024-3205(75)90176-9

M3 - Article

C2 - 173950

AN - SCOPUS:0016676004

VL - 17

SP - 1551

EP - 1556

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 10

ER -